Your browser doesn't support javascript.
loading
Survival trends of patients with oral and oropharyngeal cancer treated at a cancer center in São Paulo, Brazil
Kowalski, Luiz Paulo; Oliveira, Max Moura de; Lopez, Rossana Veronica Mendoza; Silva, Diego Rodrigues Mendonça e; Ikeda, Mauro Kazuo; Curado, Maria Paula.
  • Kowalski, Luiz Paulo; A.C. Camargo Cancer Center. Departamento de Cirurgia de Cabeca e Pescoco e Otorrinolaringologia. Sao Paulo. BR
  • Oliveira, Max Moura de; A.C. Camargo Cancer Center. Centro Internacional de Pesquisa. Grupo de Epidemiologia e Estatistica em Cancer. Sao Paulo. BR
  • Lopez, Rossana Veronica Mendoza; A.C. Camargo Cancer Center. Centro Internacional de Pesquisa. Grupo de Epidemiologia e Estatistica em Cancer. Sao Paulo. BR
  • Silva, Diego Rodrigues Mendonça e; A.C. Camargo Cancer Center. Centro Internacional de Pesquisa. Grupo de Epidemiologia e Estatistica em Cancer. Sao Paulo. BR
  • Ikeda, Mauro Kazuo; A.C. Camargo Cancer Center. Departamento de Cirurgia de Cabeca e Pescoco e Otorrinolaringologia. Sao Paulo. BR
  • Curado, Maria Paula; A.C. Camargo Cancer Center. Centro Internacional de Pesquisa. Grupo de Epidemiologia e Estatistica em Cancer. Sao Paulo. BR
Clinics ; 75: e1507, 2020. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1101092
ABSTRACT
OBJECTIVE: We aimed to estimate the overall survival (OS) and conditional survival (CS) in patients diagnosed with oral and oropharyngeal squamous cell carcinoma (SCC) and to determine their survival trends. METHODS: The study included all consecutive patients treated at the A.C. Camargo Cancer Center for oral or oropharyngeal SCC between 2001 and 2012. Data were obtained from the Hospital Cancer Registry. OS and CS were analyzed using the Kaplan-Meier method to evaluate the probability of survival with Cox predictor models. RESULTS: Data of 505 oral and 380 oropharyngeal SCC patients obtained in 2001-2006 and 2007-2012 were analyzed. Most of the oral SCC (59%) and oropharyngeal SCC (90%) patients had stages III-IV SCC. The 5-year OS for patients with oral SCC was 51.7%, with no significant difference between the first and second periods. The CS rates in 2007-2012 were 65% after the first year and 86% up to the fifth year. For oropharyngeal SCC, the 5-year OS rate was 45.0% in the first period. The survival rate increased to 49.1% from 2007 to 2012, with a reduction in the risk of death (HR=0.69;0.52-09.2). The CS estimates from 2007 to 2012 were 59% after the first year and 75% up to the fifth year. CONCLUSION: Survival across the two time periods remained stable for oral SCC but showed a significant increase for oropharyngeal SCC, possibly because of improvements in the patients' response to radiotherapy, such as intensity-modulated radiation therapy, and the use of more accurate diagnostic imaging approaches.
Asunto(s)


Texto completo: Disponible Índice: LILACS (Américas) Asunto principal: Neoplasias de la Boca / Carcinoma de Células Escamosas / Neoplasias Orofaríngeas Tipo de estudio: Estudio observacional / Estudio pronóstico / Factores de riesgo Límite: Adulto / Anciano / Aged80 / Femenino / Humanos / Masculino País/Región como asunto: America del Sur / Brasil Idioma: Inglés Revista: Clinics Asunto de la revista: Medicina Año: 2020 Tipo del documento: Artículo País de afiliación: Brasil Institución/País de afiliación: A.C. Camargo Cancer Center/BR

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Índice: LILACS (Américas) Asunto principal: Neoplasias de la Boca / Carcinoma de Células Escamosas / Neoplasias Orofaríngeas Tipo de estudio: Estudio observacional / Estudio pronóstico / Factores de riesgo Límite: Adulto / Anciano / Aged80 / Femenino / Humanos / Masculino País/Región como asunto: America del Sur / Brasil Idioma: Inglés Revista: Clinics Asunto de la revista: Medicina Año: 2020 Tipo del documento: Artículo País de afiliación: Brasil Institución/País de afiliación: A.C. Camargo Cancer Center/BR